Patent Assignment
Reel/Frame 062254/0888
Security Interest
Recorded: 2022-12-30
Pages: 15
Assignors
HELSINN HEALTHCARE SA
Executed: 2022-12-30
HELSINN THERAPEUTICS (U.S.), INC.
Executed: 2022-12-30
HELSINN BIREX PHARMACEUTICALS LIMITED
Executed: 2022-12-30
Assignee
HAMILTON SA LLC
C/O OBERLAND CAPITAL MANAGEMENT LLC, 1700 BROADWAY, 37TH FLOOR, NEW YORK, NEW YORK, 10019
Covered Properties
(73)
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Substituted 4-Phenyl Pyridines Having Anti-Emetic Effect
Patent:
8,426,450 →
Application:
13/478,361 →
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Asymmetric Ureas and Medical Uses Thereof
Liquid Pharmaceutical Formulations of Palonosetron
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Liquid Pharmaceutical Formulations of Palonosetron
4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM AS A NEUROKININ RECEPTOR MODULATOR
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Liquid Pharmaceutical Formulations of Palonosetron
Asymmetric Piperidinyl-Substituted Ureas as Medicines
Medical Treatments Based on Anamorelin
Asymmetric Ureas and Medical Uses Thereof
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Substituted Piperaziniums for the Treatment of Emesis
Substituted Asymmetric Ureas as Modulators of Ghrelin Receptor Activity
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Crystalline Forms of an NK-1 Antagonist
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Crystal Forms of Anamorelin
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Crystalline Forms of Fosnetupitant
SOLUTION COMPRISING THE CHLORIDE HYDROCHLORIDE SALT OF 4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM (FOSNETUPITANT) AND PALONOSETRON HYDROCHLORIDE IN COMBINATION WITH DEXAMETHASONE AS A NEUROKININ RECEPTOR MODULATOR
Crystalline Forms of an NK-1 Antagonist
Medical Treatments Based on Anamorelin
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Asymmetric Ureas and Medical Uses Thereof
Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Substituted Asymmetric Ureas as Modulators of Ghrelin Receptor Activity
Physiologically Balanced Injectable Formulations of Fosnetupitant
Crystalline Forms of an Nk-1 Antagonist
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
Fumarate Salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, Methods of Preparation, and Uses Thereof
Physiologically Balanced Injectable Formulations of Fosnetupitant
Fumarate Salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, Methods of Preparation, and Uses Thereof
Substituted Piperaziniums for the Treatment of Emesis
Medical Treatments Based on Anamorelin
Crystalline Forms of an Nk-1 Antagonist
Fosnetupitant Chloride Hydrochloride Having Improved Stability
Medical Treatments Based on Anamorelin
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Crystalline Forms of an Nk-1 Antagonist
Methods of Manufacturing Anamorelin Tablets Having Improved Stability
Application:
17/634,616 →
Publication:
US 2022/0323430
Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide
Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide
Methods of Treating Emesis
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Stabilized Compositions of Alkylating Agents and Methods of Using Same
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Stabilized Compositions of Alkylating Agents and Methods of Using Same
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Use of Anamorelin to Treat Cancer-Related Fatigue
Application:
63/212,148 →
Use of Anamorelin to Treat Cancer-Related Fatigue
Application:
17/838,308 →
Publication:
US 2022/0401429
New Centrally-Active Ghrelin Agonist and Medical Uses Thereof
Physiologically Balanced Injectable Formulations of Fosnetupitant
Process for the Synthesis of Substituted Chloromethyl Dialkylphosphates
Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof
Methods for Treating Skin Disorders with a Topical Composition of Bis-(2-Chloroethyl)Methylamine
Application:
15/804,804 →
Publication:
US 2018/0125797
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 21, 2006
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 017831/0234 →
Assignment of Assignor's Interest
Dec 6, 2010
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 025450/0180 →
Assignment of Assignor's Interest
Feb 16, 2011
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 025819/0244 →
Assignment of Assignor's Interest
Feb 16, 2011
From: CALDERARI, GIORGIO; BONADEO, DANIEL; BRAGLIA, ENRICO; BRAGLIA, RICCARDO
To: HELSINN HEALTHCARE SA
Reel/Frame 025816/0283 →
Assignment of Assignor's Interest
Feb 16, 2011
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 025816/0579 →
Assignment of Assignor's Interest
Feb 16, 2011
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 025819/0334 →
Assignment of Assignor's Interest
Apr 1, 2011
From: TRENTO, FABIO; CANTOREGGI, SERGIO; ROSSI, GIORGIA; CANNELLA, ROBERTA
To: HELSINN HEALTHCARE S.A.
Reel/Frame 026059/0473 →
Assignment of Assignor's Interest
Sep 5, 2012
From: CALDERARI, GIORGIO; BONADEO, DANIEL; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 028899/0100 →
Assignment of Assignor's Interest
Nov 15, 2012
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 029302/0296 →
Assignment of Assignor's Interest
Nov 28, 2012
From: FADINI, LUCA; MANINI, PETER; PIETRA, CLAUDIO; GIULIANO, CLAUDIO
To: HELSINN HEALTHCARE SA
Reel/Frame 029365/0544 →
Assignment of Assignor's Interest
May 23, 2013
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; MACCIOCCHI, SIMONE
To: HELSINN HEALTHCARE SA
Reel/Frame 030478/0960 →
Assignment of Assignor's Interest
May 23, 2013
From: MACCIOCCHI, SIMONE; MACCIOCCHI, GIULIO
To: HELSINN HEALTHCARE SA
Reel/Frame 030478/0304 →
Assignment of Assignor's Interest
May 23, 2013
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 030479/0001 →
Assignment of Assignor's Interest
Jul 17, 2013
From: GARCIA RUBIO, SILVINA; PIETRA, CLAUDIO; GIULIANO, CLAUDIO; LI, ZHIGANG
To: HELSINN HEALTHCARE SA
Reel/Frame 030813/0657 →
Assignment of Assignor's Interest
Jan 15, 2015
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M.
To: ROCHE PALO ALTO LLC
Reel/Frame 034725/0563 →
Assignment of Assignor's Interest
Jan 15, 2015
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; MACCIOCCHI, SIMONE
To: HELSINN HEALTHCARE SA
Reel/Frame 034725/0403 →
Assignment of Assignor's Interest
Feb 4, 2015
From: TRENTO, FABIO; CANTOREGGI, SERGIO; ROSSI, GIORGIA; CANNELLA, ROBERTA
To: HELSINN HEALTHCARE SA
Reel/Frame 034887/0105 →
Assignment of Assignor's Interest
Feb 4, 2015
From: TRENTO, FABIO; CANTOREGGI, SERGIO; ROSSI, GIORGIA; CANNELLA, ROBERTA
To: HELSINN HEALTHCARE SA
Reel/Frame 034886/0944 →
Assignment of Assignor's Interest
Feb 4, 2015
From: TRENTO, FABIO; CANTOREGGI, SERGIO; ROSSI, GIORGIA; CANNELLA, ROBERTA
To: HELSINN HEALTHCARE SA
Reel/Frame 034886/0682 →
Assignment of Assignor's Interest
May 11, 2016
From: ROCHE PALO ALTO LLC
To: HELSINN HEALTHCARE SA
Reel/Frame 038544/0269 →
Assignment of Assignor's Interest
Nov 14, 2018
From: CALDERARI, GIORGIO; BONADEO, DANIEL; CANNELLA, ROBERTA; BRAGLIA, ENRICO
To: HELSINN HEALTHCARE SA
Reel/Frame 047498/0871 →
Assignment of Assignor's Interest
Nov 14, 2018
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M
To: ROCHE PALO ALTO LLC
Reel/Frame 047498/0886 →
Assignment of Assignor's Interest
Nov 14, 2018
From: CALDERARI, GIORGIO; BONADEO, DANIELE; CANNELLA, ROBERTA; MACCIOCCHI, ALBERTO
To: HELSINN HEALTHCARE SA
Reel/Frame 047498/0916 →
Assignment of Assignor's Interest
Nov 14, 2018
From: MIKSZTAL, ANDREW; MALEFYT, THOMAS; LEE, KATHLEEN M
To: ROCHE PALO ALTO LLC
Reel/Frame 047498/0945 →
Patent Co-Ownership Agreement
Nov 14, 2018
From: HELSINN HEALTHCARE SA
To: HELSINN ADVANCED SYNTHESIS SA; HELSINN BIREX PHARMACEUTIALS LTD.; HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 047534/0024 →